Cargando…

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Genetic and epigenetic alterations have been identified frequently in lung cancer, such as promoter methylation, gene mutations and genomic amplification. However, the interaction between genetic and epigenetic events an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Meiju, Guan, Haixia, Gao, Cuixia, Shi, Bingyin, Hou, Peng
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098185/ https://www.ncbi.nlm.nih.gov/pubmed/21507233 http://dx.doi.org/10.1186/1471-2407-11-147

Ejemplares similares

Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
por: Shi, Jing, et al.
Publicado: (2012)

Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
por: Shi, Jing, et al.
Publicado: (2012)

PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies
por: Scheffler, Matthias, et al.
Publicado: (2014)

Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
por: Kim, Joo Hoon, et al.
Publicado: (2016)

Clinicopathological Characteristics of PIK3CA Mutation and Amplification in Korean Patients with Breast Cancers
por: Lee, Moo-Hyun, et al.
Publicado: (2020)

Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
por: Murat, C.B., et al.
Publicado: (2012)

Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
por: Berenjeno, Inma M., et al.
Publicado: (2017)

Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter
por: Zhang, Lihong, et al.
Publicado: (2011)

Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification
por: Xing, Jeffrey C., et al.
Publicado: (2012)

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway
por: Fu, Jiao, et al.
Publicado: (2013)

Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway
por: Wang, Liping, et al.
Publicado: (2015)

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
por: Janku, Filip, et al.
Publicado: (2011)

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
por: Murakami, Kosuke, et al.
Publicado: (2021)

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant
por: Correia, Lizelle, et al.
Publicado: (2022)

PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma
por: Cui, Wenli, et al.
Publicado: (2017)

PIK3CA mutations are frequently observed in BRCAX but not BRCA2 -associated male breast cancer
por: Deb, Siddhartha, et al.
Publicado: (2013)

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
por: Wang, Lei, et al.
Publicado: (2014)

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2016)

PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
por: Essakly, Ahlem, et al.
Publicado: (2019)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations
por: Brouillard, Pascal, et al.
Publicado: (2021)

Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival
por: Wei, Jing, et al.
Publicado: (2019)

Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3
por: Lv, Yanyan, et al.
Publicado: (2016)

Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
por: Zhao, Jiayi, et al.
Publicado: (2019)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2015)

Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer
por: Huw, L-Y, et al.
Publicado: (2013)

Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation
por: Sato, Seiya, et al.
Publicado: (2023)

Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes
por: Kim, Ji-Yeon, et al.
Publicado: (2017)

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
por: Lu, Hong-Yang, et al.
Publicado: (2018)

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
por: Gao, Ke, et al.
Publicado: (2015)

Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015)

PIK3CA Gene Amplification and PI3K p110α Protein Expression in Breast Carcinoma
por: Firoozinia, Mohammad, et al.
Publicado: (2014)

PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2016)

Genetic alterations and PIK3CA gene mutations and amplifications analysis in cervical cancer by racial groups in the United States
por: Femi, Odekunle Florence
Publicado: (2018)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Mutations in PIK3CA are infrequent in neuroblastoma
por: Dam, Vincent, et al.
Publicado: (2006)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_plpopskv62u82l1b19jssldbdj